Site icon pharmaceutical daily

Ablynx issues additional common shares as result of warrant exercise

Ablynx

Ablynx

Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.

As a result of this transaction, Ablynx now has 61,076,074 shares outstanding.

The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights currently is 2,457,038 which equals the total number of voting rights that may result from the exercise of these warrants. Currently 1,000 convertible bonds are outstanding entitling the holders thereof to 7,733,952 shares of the company in the aggregate, upon conversion of such convertible bonds.

Exit mobile version